(Q33720105)

28 July 2017

1 reference

title

Structure-activity relationships of anandamide, an endogenous cannabinoid ligand (English)

1 reference

28 July 2017

0 references

0 references

Alexandros Makriyannis

series ordinal

2

object named as

A Makriyannis

1 reference

28 July 2017

A D Khanolkar

1

1 reference

PubMed ID

10462061

28 July 2017

language of work or name

English

0 references

publication date

1 January 1999

1 reference

28 July 2017

1 reference

28 July 2017

65

1 reference

28 July 2017

6-7

1 reference

28 July 2017

607-616

1 reference

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

28 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900283-0

Two new unsaturated fatty acid ethanolamides in brain that bind to the cannabinoid receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900283-0

A second endogenous cannabinoid that modulates long-term potentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900283-0

Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900283-0

Anandamide, a brain endogenous compound, interacts specifically with cannabinoid receptors and inhibits adenylate cyclase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900283-0

Inhibitory effects of certain enantiomeric cannabinoids in the mouse vas deferens and the myenteric plexus preparation of guinea-pig small intestine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900283-0

Effect of phenylmethylsulphonyl fluoride on the potency of anandamide as an inhibitor of electrically evoked contractions in two isolated tissue preparations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900283-0

Anandamide, an endogenous ligand of the cannabinoid receptor, induces hypomotility and hypothermia in vivo in rodents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900283-0

Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900283-0

Anandamide amidohydrolase activity in rat brain microsomes. Identification and partial characterization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900283-0

Formation and inactivation of endogenous cannabinoid anandamide in central neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900283-0

Functional role of high-affinity anandamide transport, as revealed by selective inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900283-0

Molecular characterization of a peripheral receptor for cannabinoids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900283-0

Structural requirements for binding of anandamide-type compounds to the brain cannabinoid receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900283-0

Novel analogues of arachidonylethanolamide (anandamide): affinities for the CB1 and CB2 cannabinoid receptors and metabolic stability.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900283-0

Pharmacological and behavioral evaluation of alkylated anandamide analogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900283-0

(R)-methanandamide: a chiral novel anandamide possessing higher potency and metabolic stability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900283-0

Head group analogs of arachidonylethanolamide, the endogenous cannabinoid ligand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900283-0

Conformational analysis of arachidonic and related fatty acids using molecular dynamics simulations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900283-0

Exploration of biologically relevant conformations of anandamide, 2-arachidonylglycerol, and their analogues using conformational memories

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900283-0

Derivation of a pharmacophore model for anandamide using constrained conformational searching and comparative molecular field analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900283-0

Structure-activity analysis of anandamide analogs: relationship to a cannabinoid pharmacophore.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900283-0

Synthesis and pharmacological comparison of dimethylheptyl and pentyl analogs of anandamide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900283-0

Potent Anandamide Analogs: The Effect of Changing the Length and Branching of the End Pentyl Chain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900283-0

Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900283-0

High-performance liquid chromatographic determination of anandamide amidase activity in rat brain microsomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900283-0

Determination of anandamide amidase activity using ultraviolet-active amine derivatives and reverse-phase high-performance liquid chromatography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900283-0

Substrate specificity and stereoselectivity of rat brain microsomal anandamide amidohydrolase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900283-0

Anandamide amidohydrolase reacting with 2-arachidonoylglycerol, another cannabinoid receptor ligand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900283-0

Fatty acid sulfonyl fluorides inhibit anandamide metabolism and bind to the cannabinoid receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900283-0

Methyl arachidonyl fluorophosphonate: a potent irreversible inhibitor of anandamide amidase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900283-0

Inhibition of anandamide amidase activity in mouse brain microsomes by cannabinoids.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900283-0

10.1016/S0024-3205(99)00283-0

7 January 2021

Identifiers

DOI

1 reference

28 July 2017

1 reference

PubMed ID

10462061